Ipamorelin 15mg is a highly selective growth hormone secretagogue pentapeptide evaluated in preclinical models for its ability to stimulate GH secretion without triggering significant cortisol or prolactin release. Formulated at a high-yield 15 milligram mass for extended laboratory assays, this compound provides researchers with an exceptional tool for studying somatotropic signaling pathways, nitrogen retention, and cellular growth dynamics under rigorous laboratory conditions.
Ipamorelin 15mg is a highly selective growth hormone secretagogue pentapeptide evaluated in preclinical models for its ability to stimulate GH secretion without triggering significant cortisol or prolactin release. Formulated at a high-yield 15 milligram mass for extended laboratory assays, this compound provides researchers with an exceptional tool for studying somatotropic signaling pathways, nitrogen retention, and cellular growth dynamics under rigorous laboratory conditions.
In analytical chemistry and preclinical biology, ipamorelin 15mg represents a high-purity pentapeptide configuration designed specifically for in vitro research and animal model investigation. Belonging to the growth hormone secretagogue receptor (GHSR-1a) agonist class, ipamorelin mimic ghrelin action at the pituitary gland level. Its specific peptide sequence (Aib-His-D-2Nal-D-Phe-Lys-NH2) confers exceptional stability and selectivity during controlled laboratory exposure.
Researchers utilizing the 15mg vial format benefit from an optimal quantitative yield for extended multi-well culture protocols or longitudinal rodent bioassays. By engaging the GHSR-1a receptor without activating glucocorticoid or lactotropic pathways, ipamorelin serves as a baseline control standard when isolating pure growth hormone dynamics from non-specific endocrine stress responses.
The molecular architectural identity of ipamorelin relies on its unnatural amino acid substitutions, which inhibit rapid enzymatic degradation by circulating peptidases in ex vivo tissue preparations. Unlike native ghrelin, which exhibits broader signaling downstream, ipamorelin preferentially activates the G-protein coupled receptor GHSR-1a to trigger intracellular calcium ion influx within pituitary somatotrophs, promoting exocytosis of stored growth hormone granules.
A key defining feature demonstrated across preclinical literature is ipamorelin's lack of binding affinity for adrenocorticotropic hormone (ACTH) or prolactin release receptors. While earlier secretagogues induce concurrent spikes in plasma cortisol and prolactin, ipamorelin demonstrates near-complete selectivity for GH release. This specific pathway activation allows investigators to isolate somatotropic signaling networks without confounding metabolic stress variables or prolactin-mediated signaling events.
When designing comparative endocrine assays, selecting the appropriate peptide candidate depends on receptor binding kinetics and target specificity. While ipamorelin 15mg is favored for clean GH activation, researchers frequently compare its mechanism against related secretagogues across our all-peptides catalog to evaluate synergistic or divergent downstream cascades.
For example, combining ipamorelin with a growth hormone releasing hormone (GHRH) analog such as cjc-1295-no-dac or sermorelin demonstrates amplified, dual-receptor signaling in pituitary cell cultures—as GHRH and GHSR-1a utilize complementary cAMP and phosphoinositide pathways. Conversely, earlier-generation ghrelin mimetics like ghrp-2 and ghrp-6 induce pronounced elevations in appetite signaling and cortisol secretion in rodent models. Newer hexapeptide analogs like hexarelin offer potent GH output but display rapid receptor desensitization compared to the sustained pulsatile response observed with ipamorelin.
In preclinical studies evaluating skeletal muscle cellular biology, ipamorelin is regularly employed to measure protein synthesis rates, satellite cell activation, and nitrogen balance under catabolic conditions. Experimental animal models subjected to simulated disuse atrophy or oxidative stress exhibit altered insulin-like growth factor 1 (IGF-1) expression profiles when exposed to secretagogue protocols. Detailed mechanism pathways can be referenced within our research library.
Furthermore, tissue engineering assays assess ipamorelin's influence on osteoblast differentiation and collagen deposition in rodent bone defect models. Because ipamorelin maintains natural pulsatile GH patterns rather than continuous non-physiological elevations, research indicates that target tissues preserve receptor sensitivity over prolonged exposure periods. Investigators studying metabolic signaling pathways utilize these properties to monitor lipid oxidation and glucose homeostatic adjustments in laboratory settings.
To ensure reliable and reproducible experimental outcomes, PX1 Research subjects every production lot of ipamorelin 15mg to a comprehensive suite of analytical verifications. Lyophilized peptide cakes undergo high-performance liquid chromatography (RP-HPLC) to establish chemical purity, mandating a baseline purity threshold exceeding 99.0%. Mass spectrometry (ESI-MS) confirms exact molecular mass identity, ruling out sequence truncation or synthesis impurities.
Understanding that bacterial lipopolysaccharides can disrupt cellular assays and induce non-specific inflammatory cytokines in animal models, PX1 Research subjects all research-peptides to rigorous Limulus Amebocyte Lysate (LAL) endotoxin testing. Every lot is verified to maintain endotoxin levels strictly below <0.01 EU/mg, manufactured in state-of-the-art US-based GMP-compliant facilities and tested by ISO 17025 accredited laboratories.
Proper reconstitution technique is essential for preserving peptide structural integrity prior to analytical testing. Standard laboratory protocols dictate bringing the lyophilized ipamorelin 15mg vial to room temperature prior to introducing solvent to prevent moisture condensation within the container. Sterile bacteriostatic water or standard phosphate-buffered saline (PBS, pH 7.4) should be gently introduced along the inner glass wall of the vial.
Vigorous shaking or high-shear agitation must be avoided, as physical shearing can disrupt the secondary peptide structure or lead to aggregation. Gentle rotation or passive dissolution over several minutes yields a clear, colorless solution. Reconstituted aliquots prepared for wholesale or institutional lab projects should be divided into single-use working volumes using sterile, low-binding polypropylene microcentrifuge tubes to prevent micro-adsorption to container walls.
In its original lyophilized state, ipamorelin 15mg exhibits high thermodynamic stability when kept sealed from atmospheric moisture and direct light. Long-term storage at -20°C or -80°C maintains chemical stability for extended periods. Short-term storage at refrigerated temperatures (2°C to 8°C) is acceptable for sealed vials during active protocol phases.
Once reconstituted into liquid phase, the peptide exhibits heightened susceptibility to hydrolytic degradation. Aqueous solutions should be kept refrigerated at 2°C to 8°C and evaluated within 28 days if preserved with bacteriostatic benzyl alcohol, or used immediately if dissolved in unpreserved sterile water. Repeated freeze-thaw cycles must be avoided to prevent peptide precipitation and potency decline.
PX1 Research streamlines laboratory procurement by maintaining robust domestic inventory directly sourced from US manufacturing facilities. Researchers ordering ipamorelin 15mg receive full lot-specific transparency, including a downloadable, third-party Certificate of Analysis (COA) matching the exact vial received.
To maintain strict supply chain integrity and eliminate transit delays that could expose peptides to environmental stress, PX1 Research operates dual fulfillment centers in California and Arizona. Orders processed before cutoff times ship same-day (Monday through Friday) using temperature-monitored, protective packaging designed to preserve product purity from facility to laboratory.
What is ipamorelin 15mg used for in research?
Ipamorelin 15mg is a growth hormone secretagogue pentapeptide evaluated in laboratory research for studying selective GH release mechanisms, pituitary receptor binding kinetics, nitrogen retention, and cellular growth pathways without elevating cortisol or prolactin.
How does ipamorelin differ from earlier secretagogues like GHRP-2 or GHRP-6?
Unlike GHRP-2 and GHRP-6, which trigger non-specific endocrine responses including elevated cortisol, prolactin, and intense appetite stimulation, ipamorelin is highly selective for the GHSR-1a receptor and isolates GH release without activating glucocorticoid stress cascades.
What analytical methods verify the purity of PX1 Research ipamorelin 15mg?
PX1 Research verifies each lot using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm >99% chemical purity, Electrospray Ionization Mass Spectrometry (ESI-MS) for sequence confirmation, and LAL testing to ensure endotoxin levels remain below 0.01 EU/mg.
Is a Certificate of Analysis (COA) available for ipamorelin 15mg?
Yes. Every single batch of ipamorelin 15mg distributed by PX1 Research includes a third-party ISO 17025 accredited Certificate of Analysis showing lot-specific HPLC chromatograms, mass spec mass verification, and endotoxin assay results.
How should lyophilized ipamorelin 15mg be stored upon arrival?
Lyophilized vials should be stored protected from light at -20°C for long-term research applications or at 2°C to 8°C for short-term active study phases. Keep vials tightly sealed in a low-humidity environment.
What diluents are suitable for reconstituting ipamorelin 15mg in a laboratory setting?
Ipamorelin 15mg can be reconstituted using sterile bacteriostatic water (containing 0.9% benzyl alcohol) for multi-use analytical sampling or sterile 0.9% sodium chloride/PBS for immediate single-application in vitro protocols.
How stable is ipamorelin 15mg once dissolved in solution?
Reconstituted ipamorelin solutions remain stable for up to 28 days when preserved with bacteriostatic water and stored at 2°C to 8°C. Solutions without preservative should be used immediately. Avoid subjecting reconstituted solutions to multiple freeze-thaw cycles.
Can ipamorelin be combined with GHRH analogs in experimental protocols?
Yes, in preclinical models, researchers frequently study secretagogues like ipamorelin alongside GHRH peptides such as CJC-1295 or Sermorelin to observe synergistic growth hormone release mediated by distinct receptor signaling pathways.
Where is PX1 Research ipamorelin 15mg manufactured and shipped from?
PX1 Research peptides are synthesized in US-based GMP-compliant facilities and shipped directly from our primary fulfillment centers in California and Arizona with same-day shipping available Monday through Friday.
Does PX1 Research supply ipamorelin 15mg for institutional or bulk lab orders?
Yes, PX1 Research provides institutional accounts, university laboratories, and commercial facilities with high-volume procurement options and custom batch analytical documentation via our dedicated wholesale program.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.